Overview

Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600

Status:
Completed
Trial end date:
2020-09-10
Target enrollment:
Participant gender:
Summary
Study to Evaluate the Effect of Repeat-Dose Rifampin on the pharmacokinetics (PK) of PF-06651600.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Rifampin